Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Date of authorisation: 26/07/2018, Revision: 19, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 16 February 2026 - 8:56

Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Date of authorisation: 26/07/2018, Revision: 19, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/hefiya

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters